FDA — authorised 7 October 2016
- Application: ANDA206006
- Marketing authorisation holder: RISING
- Status: supplemented
FDA authorised Amoxicillin, Clarithromycin on 7 October 2016
Yes. FDA authorised it on 7 October 2016.
RISING holds the US marketing authorisation.